Global Atrial Fibrillation Market By Product (Surgical Devices, Non-Surgical Devices, Pharmacological Drugs), Type (Paroxysmal, Others), End User (Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Atrial Fibrillation Market
Atrial fibrillation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 12.06 billion by 2027 growing at a CAGR of 11.50% in the above-mentioned forecast period. Increasing health awareness among the people and rising benefits of atrial fibrillation which will help in driving the growth of the market.
Surging volume of patients suffering from heart related disorders, growing number of geriatric population across the globe, increasing medical tourism, rising preferences towards catheter ablation for cardiac arrhythmia treatment which will likely to enhance the growth of the atrial fibrillation market in the forecast period of 2020-2027. On the other hand, rising advancement in technology along with increasing applications from emerging economies which will further bring various opportunities for the growth of the atrial fibrillation market in the above mentioned forecast period.
Lack of skilled and trained personnel, unfavourable preferences to pharmaceutical drugs over AF treatment devices along with high recurrence and complication rates are acting as market restraints for the growth of the atrial fibrillation in the above mentioned forecast period.
This atrial fibrillation market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on atrial fibrillation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Atrial Fibrillation Market Scope and Market Size
Atrial fibrillation market is segmented on the basis of product, type, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product, atrial fibrillation market is segmented into surgical devices, pharmacological drugs, and non-surgical devices. Surgical devices have been further segmented into maze surgery, catheter ablation, radiofrequency catheter ablation, cryoablation, microwave based catheter ablation, laser based catheter ablation, and navigational advanced mapping accessories. Radiofrequency catheter ablation has been further sub segmented into conventional RF ablation catheters, and irrigated-tip RF ablation catheters. Non-surgical devices have been further segmented into electric cardioversion, diagnostic catheters, conventional diagnostic catheters, advanced diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage and closure devices, and intracardiac echocardiography (ICE) systems. Conventional diagnostic catheters have been further sub segmented into fixed diagnostic catheters, and steerable diagnostic catheters. Pharmacological drugs have been further segmented into anti-arrhythmic drugs, and anti-coagulant drugs.
- Based on type, atrial fibrillation market is segmented into paroxysmal, and others.
- Atrial fibrillation market has also been segmented based on the end user into hospitals, electrophysiology labs, and ambulatory surgical centers.
Atrial Fibrillation Market Country Level Analysis
Atrial fibrillation market is analysed and market size insights and trends are provided by country, product, type, and end user as referenced above.
The countries covered in the atrial fibrillation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the atrial fibrillation market due to the growing number of healthcare expenditure along with prevalence of improved infrastructure, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the growing number of geriatric population and rising disposable income of the people.
The country section of the atrial fibrillation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Atrial fibrillation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for atrial fibrillation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the atrial fibrillation market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Atrial Fibrillation Market Share Analysis
Atrial fibrillation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to atrial fibrillation market.
The major players covered in the atrial fibrillation market report are Abbott, Johnson & Johnson Services, Inc., MicroPort Scientific Corporation., Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens AG, AtriCure, Inc., sanofi-aventis U.S. LLC, Biosense Webster, Inc, CardioFocus., BRISTOL-MYERS SQUIBB, Boehringer Ingelheim International GmbH., OSYPKA AG, Vanguard AG, GENERAL ELECTRIC COMPANY, Pfizer Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.